Global Advanced Cancer Diagnostics Market Size & Outlook
Global advanced cancer diagnostics market, 2021-2033 (US$M)
Global advanced cancer diagnostics market highlights
- The global advanced cancer diagnostics market generated a revenue of USD 58,300.0 million in 2024 and is expected to reach USD 127,071.0 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 9.1% by 2033.
- In terms of segment, tumor marker tests accounted for a revenue of USD 63,538.9 million in 2024.
- Tumor Marker Tests is the most lucrative test segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
Global data book summary
| Market revenue in 2024 | USD 58,300.0 million |
| Market revenue in 2033 | USD 127,071.0 million |
| Growth rate | 9.1% (CAGR from 2025 to 2033) |
| Largest segment | Tumor marker tests |
| Fastest growing segment | Tumor Marker Tests |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tumor Marker Tests |
Other key industry trends
- In terms of revenue, the North America accounted for 41.9% of the global advanced cancer diagnostics market in 2024.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Advanced Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Roche Diagnostics | View profile | - | - | - |
| Becton Dickinson and Company | View profile | - | - | - |
| Canon Medical Systems Corp. | View profile | - | - | - |
| Philips | View profile | 10001+ | Amsterdam, Noord-Holland, The Netherlands, Europe | https://www.usa.philips.com |
| Bruker Corp | View profile | 9707 | 40 Manning Road, Billerica, MA, United States, 01821 | https://www.bruker.com |
| Myriad Genetics Inc | View profile | 2700 | 320 Wakara Way, Salt Lake City, UT, United States, 84108 | https://www.myriad.com |
| Bio-Rad Laboratories Inc | View profile | 8030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | https://www.bio-rad.com |
| Agilent Technologies Inc | View profile | 17700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | https://www.agilent.com |
| Illumina Inc | View profile | 9300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | https://www.illumina.com |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| FUJIFILM Holdings Corp | View profile | 83784 | 7-3, Akasaka 9-chome, Minato-ku, Tokyo, Japan, 107-0052 | http://www.fujifilmholdings.com |
| Siemens Healthineers AG ADR | View profile | 71400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | https://www.siemens-healthineers.com |
| GE HealthCare Technologies Inc Common Stock | View profile | 51000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | https://www.gehealthcare.com |
Global advanced cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to advanced cancer diagnostics market will help companies and investors design strategic landscapes.
Tumor marker tests was the largest segment with a revenue share of 108.99% in 2024. Horizon Databook has segmented the Global advanced cancer diagnostics market based on tumor marker tests covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Advanced Cancer Diagnostics Test Outlook (Revenue, USD Million, 2021-2033)
- Tumor Marker Tests
- Fine Needle Aspiration Cytology (FNAC) & Biopsy
- Imaging-Based Diagnostics
- Bone Marrow Aspiration & Biopsy
- Immunohistochemistry (IHC) & Molecular Testing
- Genetic Testing for Cancer
- Liquid Biopsy
- Global Advanced Cancer Diagnostics End Use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals & Cancer Specialty Centers
- Diagnostic Laboratories (Independent & Reference Labs)
- Research & Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Others (Outpatient Clinics, Ambulatory Centers)
Reasons to subscribe to Global advanced cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global advanced cancer diagnostics market databook
-
Our clientele includes a mix of advanced cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global advanced cancer diagnostics market , including forecasts for subscribers. This global databook contains high-level insights into Global advanced cancer diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global advanced cancer diagnostics market size, by regions, 2021-2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
